• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Concentrate of coagulation factor IX: viral validation of the thermoinactivation process].

作者信息

Zahorska R, Buchowicz I, Ejduk A

机构信息

Centralne Laboratorium Surowic i Szczepionek w Warszawie.

出版信息

Acta Haematol Pol. 1995;26(4):421-4.

PMID:8571744
Abstract

The coagulation factor IX obtained at the Institute of Haematology and Transfusion in Warsaw was subjected to virological validation. Two lipide enveloped viruses were used: HSV-1 and Sindbis which may be a model for the viruses of B and C types in hepatitis. It was shown that heating of the freeze-drying preparations at 80 degrees C during 72 hrs leads to full inactivation of the added model viruses.

摘要

相似文献

1
[Concentrate of coagulation factor IX: viral validation of the thermoinactivation process].
Acta Haematol Pol. 1995;26(4):421-4.
2
[Viral validation of the bio-globulin production process].
Med Dosw Mikrobiol. 1995;47(1-2):89-94.
3
Inactivation and clearance of viruses during the manufacture of high purity factor IX.高纯度凝血因子IX生产过程中病毒的灭活与清除
Biologicals. 2000 Sep;28(3):129-36. doi: 10.1006/biol.1999.0242.
4
Viral safety of a new highly purified factor VIII (OCTATE).新型高纯度凝血因子VIII(OCTATE)的病毒安全性
J Med Virol. 1996 Apr;48(4):360-6. doi: 10.1002/(SICI)1096-9071(199604)48:4<360::AID-JMV10>3.0.CO;2-F.
5
Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatography.在通过金属螯合亲和色谱法纯化高纯度凝血因子IX过程中包膜病毒和非包膜病毒的去除与灭活
Vox Sang. 1994;67 Suppl 1:69-71.
6
Inactivation of viruses and safety of stable plasma products.病毒的灭活及稳定血浆制品的安全性
Beitr Infusionsther. 1989;24:33-9.
7
[Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].[对经过两种特定病毒灭活处理(FANDHI)的高纯度人凝血因子VIII浓缩物的病毒安全性评估]
Sangre (Barc). 1996 Apr;41(2):131-6.
8
Sindbis virus as a tool for quality control of viral inactivation of heated and chemically treated plasma-derived products.
J Virol Methods. 2006 Jun;134(1-2):171-5. doi: 10.1016/j.jviromet.2006.01.001. Epub 2006 Feb 28.
9
A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.一项双病毒灭活因子IX浓缩物(15纳米过滤和溶剂/去污剂处理)与溶剂/去污剂处理的因子IX浓缩物的交叉药代动力学研究。
Thromb Haemost. 1998 Dec;80(6):919-24.
10
[Inactivation of viruses in Factor XIII concentrate by pasteurization].[通过巴氏灭菌法灭活凝血因子 XIII 浓缩物中的病毒]
Arzneimittelforschung. 1984;34(11):1524-7.